ReviewBiomedicines2021

Targeting the Interplay between Cancer Metabolic Reprogramming and Cell Death Pathways as a Viable Therapeutic Path.

Elisabetta Iessi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.